Andrew Spaventa Singular Genomics Systems, Inc. (OMIC) insider trading activity

Andrew Spaventa is Chief Executive Officer of Singular Genomics Systems, Inc.. Currently has a direct ownership of 325 shares of OMIC, which is worth approximately $6,435. The most recent transaction as insider was on Dec 16, 2024, when has been sold 306 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 325

0% 3M change

96.67% 12M change

Total Value Held $6,435

Andrew Spaventa Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 16 2024	SELL Bona fide gift	-	306 Reduced 48.49%	325 Common Stock
Dec 16 2024	SELL Open market or private sale	$3,628 $20.16 p/Share	180 Reduced 22.19%	631 Common Stock
Dec 15 2024	BUY Exercise of conversion of derivative security	-	486 Added 37.47%	811 Common Stock
Nov 12 2024	SELL Bona fide gift	-	1,212 Reduced 78.85%	325 Common Stock
Nov 12 2024	SELL Open market or private sale	$15,672 $22.55 p/Share	695 Reduced 31.14%	1,537 Common Stock
Nov 12 2024	BUY Exercise of conversion of derivative security	-	1,907 Added 46.07%	2,232 Common Stock
Sep 15 2024	SELL Bona fide gift	-	312 Reduced 48.98%	325 Common Stock
Sep 15 2024	SELL Open market or private sale	$2,166 $12.38 p/Share	175 Reduced 21.55%	637 Common Stock
Sep 15 2024	BUY Exercise of conversion of derivative security	-	487 Added 37.49%	812 Common Stock
Aug 12 2024	SELL Payment of exercise price or tax liability	$4,848 $7.12 p/Share	681 Reduced 30.52%	1,550 Common Stock
Aug 12 2024	SELL Bona fide gift	-	1,225 Reduced 79.03%	325 Common Stock
Aug 12 2024	BUY Exercise of conversion of derivative security	-	1,906 Added 46.07%	2,231 Common Stock
Jun 15 2024	SELL Bona fide gift	-	14,584 Reduced 59.89%	9,766 Common Stock
Jun 15 2024	BUY Exercise of conversion of derivative security	-	14,584 Added 37.46%	24,350 Common Stock
May 12 2024	SELL Bona fide gift	-	57,188 Reduced 85.41%	9,766 Common Stock
May 12 2024	BUY Exercise of conversion of derivative security	-	57,188 Added 46.07%	66,954 Common Stock
Mar 15 2024	SELL Bona fide gift	-	14,583 Reduced 59.89%	9,766 Common Stock
Mar 15 2024	BUY Exercise of conversion of derivative security	-	14,583 Added 37.46%	24,349 Common Stock
Dec 15 2023	SELL Bona fide gift	-	14,583 Reduced 59.89%	9,766 Common Stock
Dec 15 2023	BUY Exercise of conversion of derivative security	-	14,583 Added 37.46%	24,349 Common Stock
Sep 15 2023	SELL Bona fide gift	-	14,584 Reduced 59.89%	9,766 Common Stock
Sep 15 2023	BUY Exercise of conversion of derivative security	-	14,584 Added 37.46%	24,350 Common Stock
Jun 15 2023	SELL Bona fide gift	-	14,583 Reduced 59.89%	9,766 Common Stock
Jun 15 2023	BUY Exercise of conversion of derivative security	-	14,583 Added 37.46%	24,349 Common Stock
Mar 24 2022	BUY Other acquisition or disposition	-	9,766 Added 50.0%	9,766 Common Stock

Andrew Spaventa

Chief Executive Officer

La Jolla, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OMIC shares.

Notify only if

Value

Insider Trading

Get notified when an Singular Genomics Systems, Inc. insider buys or sells OMIC shares.

Notify only if

Operation

Value

Type

News

Receive news related to Singular Genomics Systems, Inc.

Track Activities on OMIC

Account